tiprankstipranks
Gufic Biosciences Limited (IN:GUFICBIO)
:GUFICBIO
India Market

Gufic Biosciences Limited (GUFICBIO) Ratios

0 Followers

Gufic Biosciences Limited Ratios

IN:GUFICBIO's free cash flow for Q2 2026 was ₹0.56. For the 2026 fiscal year, IN:GUFICBIO's free cash flow was decreased by ₹ and operating cash flow was ₹0.14. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
1.55 1.61 1.61 1.61 1.72
Quick Ratio
1.06 1.05 1.08 0.97 1.10
Cash Ratio
0.16 0.07 <0.01 0.10 0.06
Solvency Ratio
0.13 0.16 0.18 0.20 0.45
Operating Cash Flow Ratio
0.13 0.26 -0.02 -0.09 0.57
Short-Term Operating Cash Flow Coverage
0.26 0.57 -0.05 -0.22 8.01
Net Current Asset Value
₹ 872.66M₹ 562.36M₹ 404.98M₹ -492.43M₹ 684.70M
Leverage Ratios
Debt-to-Assets Ratio
0.29 0.29 0.30 0.39 0.12
Debt-to-Equity Ratio
0.58 0.56 0.63 0.96 0.24
Debt-to-Capital Ratio
0.37 0.36 0.38 0.49 0.19
Long-Term Debt-to-Capital Ratio
0.16 0.18 0.22 0.35 0.15
Financial Leverage Ratio
2.01 1.95 2.05 2.48 1.94
Debt Service Coverage Ratio
0.44 0.56 0.66 0.85 7.01
Interest Coverage Ratio
2.80 4.92 18.84 30.66 37.02
Debt to Market Cap
0.11 0.09 0.11 0.17 0.03
Interest Debt Per Share
40.36 35.92 35.34 35.32 7.00
Net Debt to EBITDA
2.20 2.22 2.24 2.23 0.36
Profitability Margins
Gross Profit Margin
45.71%36.23%50.50%50.87%45.73%
EBIT Margin
11.47%14.30%16.24%16.64%16.86%
EBITDA Margin
14.93%16.87%18.35%19.87%19.06%
Operating Profit Margin
11.09%13.86%35.87%36.51%16.57%
Pretax Profit Margin
7.59%11.48%14.34%15.45%16.28%
Net Profit Margin
5.58%8.50%10.68%11.54%12.30%
Continuous Operations Profit Margin
5.58%8.50%10.68%11.54%12.30%
Net Income Per EBT
73.45%73.98%74.47%74.69%75.56%
EBT Per EBIT
68.49%82.85%39.97%42.33%98.25%
Return on Assets (ROA)
3.94%5.96%7.88%9.26%18.38%
Return on Equity (ROE)
8.31%11.59%16.17%22.92%35.61%
Return on Capital Employed (ROCE)
12.41%14.53%40.16%44.00%38.54%
Return on Invested Capital (ROIC)
7.05%8.69%24.27%26.89%27.79%
Return on Tangible Assets
3.96%5.99%7.92%9.26%18.40%
Earnings Yield
1.65%2.06%3.00%4.41%3.97%
Efficiency Ratios
Receivables Turnover
2.76 2.60 2.44 3.36 5.14
Payables Turnover
2.45 3.29 2.40 2.62 3.00
Inventory Turnover
2.12 2.41 1.99 1.86 3.66
Fixed Asset Turnover
1.75 1.57 1.70 2.10 5.01
Asset Turnover
0.71 0.70 0.74 0.80 1.49
Working Capital Turnover Ratio
6.97 3.52 3.99 4.45 6.74
Cash Conversion Cycle
155.14 180.79 180.56 165.54 49.08
Days of Sales Outstanding
132.09 140.22 149.29 108.59 71.00
Days of Inventory Outstanding
172.09 151.41 183.26 196.42 99.76
Days of Payables Outstanding
149.05 110.83 151.99 139.47 121.68
Operating Cycle
304.19 291.62 332.55 305.02 170.76
Cash Flow Ratios
Operating Cash Flow Per Share
5.89 10.26 -0.76 -2.74 10.96
Free Cash Flow Per Share
4.34 2.71 -12.19 -22.09 1.94
CapEx Per Share
1.56 7.55 11.43 19.35 9.02
Free Cash Flow to Operating Cash Flow
0.74 0.26 16.11 8.06 0.18
Dividend Paid and CapEx Coverage Ratio
3.78 1.34 -0.07 -0.14 1.20
Capital Expenditure Coverage Ratio
3.78 1.36 -0.07 -0.14 1.21
Operating Cash Flow Coverage Ratio
0.16 0.31 -0.02 -0.08 1.65
Operating Cash Flow to Sales Ratio
0.07 0.13 >-0.01 -0.04 0.14
Free Cash Flow Yield
1.43%0.80%-4.19%-11.85%0.78%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
60.70 48.61 33.32 22.67 25.19
Price-to-Sales (P/S) Ratio
3.39 4.13 3.56 2.62 3.10
Price-to-Book (P/B) Ratio
4.81 5.63 5.39 5.20 8.97
Price-to-Free Cash Flow (P/FCF) Ratio
69.85 124.94 -23.89 -8.44 128.49
Price-to-Operating Cash Flow Ratio
51.38 32.99 -384.92 -67.97 22.72
Price-to-Earnings Growth (PEG) Ratio
-5.00 -2.39 5.27 -1.34 0.22
Price-to-Fair Value
4.81 5.63 5.39 5.20 8.97
Enterprise Value Multiple
24.88 26.70 21.63 15.40 16.61
Enterprise Value
33.32B 36.93B 32.02B 21.13B 24.67B
EV to EBITDA
24.88 26.70 21.63 15.40 16.61
EV to Sales
3.71 4.50 3.97 3.06 3.17
EV to Free Cash Flow
76.62 136.28 -26.65 -9.86 131.30
EV to Operating Cash Flow
56.36 35.98 -429.41 -79.46 23.22
Tangible Book Value Per Share
62.31 59.46 53.47 35.81 27.70
Shareholders’ Equity Per Share
62.93 60.09 54.04 35.88 27.76
Tax and Other Ratios
Effective Tax Rate
0.27 0.26 0.26 0.25 0.24
Revenue Per Share
89.47 81.96 81.85 71.24 80.37
Net Income Per Share
4.99 6.96 8.74 8.22 9.89
Tax Burden
0.73 0.74 0.74 0.75 0.76
Interest Burden
0.66 0.80 0.88 0.93 0.97
Research & Development to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
0.12 0.22 0.14 0.02 0.02
Stock-Based Compensation to Revenue
<0.01 0.00 0.00 0.00 0.00
Income Quality
0.84 1.47 -0.09 -0.33 1.11
Currency in INR